Article thumbnail

From GWAS to the clinic: risk factors for intracranial aneurysms

By Ynte M Ruigrok and Gabriel JE Rinkel

Abstract

Subarachnoid hemorrhage (SAH) from a ruptured intracranial aneurysm is a devastating subset of stroke, occurring in relatively young people (mean age around 50 years) of whom around a third die within the initial weeks after the bleed. Environmental and genetic risk factors both have a role in SAH. A recent genome-wide association study of intracranial aneurysms in Finnish, Dutch and Japanese cohorts totaling 5,891 cases and 14,181 controls identified three new loci strongly associated with intracranial aneurysms on chromosomes 18q11.2 and 10q24.32, and replicated two previously found loci on chromosomes 8q11.23-q12.1 and 9p21.3. However, these five intracranial aneurysm risk loci identified so far explain only up to 5% of the familial risk of intracranial aneurysms, which makes genetic risk prediction tests currently unfeasible for intracranial aneurysms. New approaches, including identification of causal variants, rare variants and copy number variants, such as insertions and deletions, may improve genetic risk prediction for SAH and intracranial aneurysms. This may lead to diagnostic tools for identifying individuals at increased risk for aneurysm formation and rupture of aneurysms. In this way, genetic diagnostic tools will identify the people who will benefit most from screening by imaging studies for aneurysms and those who are most likely to benefit from preventive treatment of incidentally discovered aneurysms

Topics: Commentary
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:3092112
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2001). Are rare variants responsible for susceptibility to complex diseases?
  2. (2010). Burden of disease and costs of aneurysmal subarachnoid haemorrhage (aSAH) in the United Kingdom. Cost Eff Resour Alloc
  3. (2008). Collins FS: A HapMap harvest of insights into the genetics of common disease.
  4. (2005). CS: Risk factors for subarachnoid hemorrhage. an updated systematic review of epidemiological studies. Stroke
  5. (2010). DB: Uncovering the roles of rare variants in common disease through whole-genome sequencing. Nat Rev Genet
  6. (1998). DR: The burden, trends, and demographics of mortality from subarachnoid hemorrhage. Neurology
  7. (2008). et al.: Meta-analysis of genomewide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet
  8. (2002). Gelder JM: The probability of sudden death from rupture of intracranial aneurysms: a meta-analysis. Neurosurgery
  9. (2007). Genetics of intracranial aneurysms. Neurosurgery
  10. (2003). Genetics of intracranial aneurysms. Neurosurgery 1997, 40:651-663. Ruigrok and Rinkel Genome Medicine 2010, 2:61 http://genomemedicine.com/content/2/9/61 Page 3 of 429. Cannon Albright
  11. (2008). Genome-wide association studies: potential next steps on a genetic journey. Hum Mol Genet
  12. (2008). Genomewide association defines more than 30 distinct susceptibility loci for Crohn’s disease. Nat Genet
  13. (2009). GJE: Changes in case fatality of aneurysmal subarachnoid haemorrhage over time, according to age, sex, and region: a meta-analysis. Lancet Neurol
  14. (2006). Inoue I: The genetics of intracranial aneurysms.
  15. (2005). IO: Deleted in liver cancer 2 (DLC2) suppresses cell transformation by means of inhibition of RhoA activity. Proc Natl Acad Sci USA
  16. (2009). Manolio TA: Potential etiologic and functional implications of genomewide association loci for human diseases and traits. Proc Natl Acad Sci USA
  17. (1997). Nabeshima YI: Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature
  18. (2010). Pennacchio LA: Targeted deletion of the 9p21 non-coding coronary artery disease risk interval in mice. Nature
  19. (2008). Personal genomes: the case of the missing heritability. Nature
  20. (2000). PH: Clinical and genetic features of Ehlers-Danlos syndrome type IV, the vascular type.
  21. (1998). Prevalence and risk of rupture of intracranial aneurysms: a systematic review. Stroke
  22. (2003). Rinkel GJE: Characteristics of intracranial aneurysms and subarachnoid haemorrhage in patients with polycystic kidney disease. J
  23. (2008). Rinkel GJE: Genetics of intracranial aneurysms. Stroke
  24. (2007). Rinkel GJE: Incidence of subarachnoid haemorrhage: a systematic review with emphasis on region, age, gender and time trends.
  25. (2010). SoxF genes: key players in the development of the cardio-vascular system.
  26. (2008). Susceptibility loci for intracranial aneurysm in European and Japanese populations. Nat Genet
  27. (1998). Toward an understanding of the functional complexity of the E2F and retinoblastoma families. Cell Growth Differ
  28. (2008). Visscher PM: Prediction of individual genetic risk of complex disease. Curr Opin Genet Dev
  29. (2010). von und zu Fraunberg